menu
    • menu

    Company profile for Kiniksa Pharmaceuticals

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kiniksa is a biotech company with an experienced team that has advanced multiple product candidates in parallel that focus on a range of debilitating diseases with significant unmet medical need. We continue to explore expanding our pipeline in order to develop life-changing medicines for patients who need it most.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kiniksa PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Kiniksa Pharmaceuticals Corp. 100 Hayden Avenue Lexington, MA 02421 USA
    Telephone
    Telephone
    (781) 431-9100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kiniksa.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kiniksa Pharma Reveals Q1 2026 Financials & Portfolio Progress
    Kiniksa Pharma Reveals Q1 2026 Financials & Portfolio Progress

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3282473/0/en/kiniksa-pharmaceuticals-reports-first-quarter-2026-financial-results-and-recent-portfolio-execution.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    Kiniksa Pharma To Release Q1 2026 Financial Results On April 28
    Kiniksa Pharma To Release Q1 2026 Financial Results On April 28

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3280354/0/en/kiniksa-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-april-28-2026.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Kiniksa Pharma To Present At TD Cowen Health Care Conference
    Kiniksa Pharma To Present At TD Cowen Health Care Conference

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244967/0/en/Kiniksa-Pharmaceuticals-to-Present-at-TD-Cowen-46th-Annual-Health-Care-Conference.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Kiniksa Pharma Reveals 2025 Financials And Portfolio Updates
    Kiniksa Pharma Reveals 2025 Financials And Portfolio Updates

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243438/0/en/Kiniksa-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Recent-Portfolio-Execution.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Kiniksa Pharma Reports Q4 and FY 2025 Financial Results
    Kiniksa Pharma Reports Q4 and FY 2025 Financial Results

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241511/0/en/Kiniksa-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-24-2026.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Roche Drops $100M Kiniksa Fibrosis Drug From Ph. 2 Pipeline
    Roche Drops $100M Kiniksa Fibrosis Drug From Ph. 2 Pipeline

    29 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/roche-drops-100m-fibrosis-drug-phase-2-pipeline-part-clearout

    FIERCE BIOTECH
    29 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search